Blue Square Asset Management, LLC Biogen Inc. Transaction History

Blue Square Asset Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$223.92 - $287.77 $681,612 - $875,971	-3,044 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $7,357 - $9,595	-26 Reduced 0.85%	3,044 $861,000
Q2 2021 Aug 04, 2021	SELL	$259.0 - $414.71 $942,760 - $1.51 Million	-3,640 Reduced 54.25%	3,070 $1.06 Million
Q1 2021 May 14, 2021	BUY	$242.95 - $284.63 $84,060 - $98,481	346 Added 5.44%	6,710 $1.88 Million
Q4 2020 Feb 08, 2021	BUY	$236.26 - $355.63 $464,959 - $699,879	1,968 Added 44.77%	6,364 $1.56 Million
Q3 2020 Nov 10, 2020	BUY	$264.77 - $305.71 $369,618 - $426,771	1,396 Added 46.53%	4,396 $1.25 Million
Q2 2020 Aug 11, 2020	SELL	$258.66 - $342.55 $140,193 - $185,662	-542 Reduced 15.3%	3,000 $803,000
Q1 2020 Apr 28, 2020	BUY	$268.85 - $341.04 $208,627 - $264,647	776 Added 28.05%	3,542 $1.12 Million
Q4 2019 Feb 04, 2020	BUY	$220.06 - $304.07 $1,760 - $2,432	8 Added 0.29%	2,766 $821,000
Q3 2019 Nov 08, 2019	BUY	$217.44 - $243.88 $599,699 - $672,621	2,758 New	2,758 $642,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Blue Square Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Blue Square Asset Management, LLC with notifications on news.